Sorry, you need to enable JavaScript to visit this website.

BESPONSA™ (inotuzumab ozogamicin) Indications and Usage

1. INDICATIONS AND USAGE

BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

What's New

No Current Announcements.

Search

Please enter your search term(s) for BESPONSA™